(Q26998471)

English

Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology

scientific article

In more languages

Statements

scholarly article

1 reference

1 reference

21 March 2019

Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology (English)

0 references

fatty liver disease

1 reference

21 March 2019

metabolic disease

1 reference

21 March 2019

1 reference

PubMed publication ID

medical guideline

1 reference

PubMed publication ID

1 reference

PubMed publication ID

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Xin Gao

1

1 reference

Jian-Gao Fan

2

1 reference

language of work or name

1 reference

publication date

December 2013

1 reference

1 December 2013

1 reference

21 March 2019

Journal of diabetes

2 references

21 March 2019

5

1 reference

4

1 reference

406-15

1 reference

copyright license

Creative Commons Attribution 3.0 Unported

1 reference

Europe PubMed Central

21 March 2019

copyright status

0 references

on focus list of Wikimedia project

0 references

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

21 March 2017

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

21 March 2017

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

21 March 2017

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

21 March 2017

Standards of medical care in diabetes--2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

Nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Nonalcoholic fatty liver disease and vascular risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Noninvasive assessment of hepatic steatosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Diagnosis and therapy of nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Non-alcoholic fatty liver disease: the mist gradually clears

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Treatment modalities of obesity: what fits whom?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Managing nonalcoholic fatty liver disease: recommendations for family physicians.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Clinical use of carotid intima-media thickness: review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

GI epidemiology: nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Nonalcoholic fatty liver disease in Asia: a story of growth

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Fatty liver and the metabolic syndrome among Shanghai adults

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 November 2018

[Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 November 2018

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 November 2018

American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of conventional serum autoantibodies for various liver diseases in a Chinese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interobserver and intraobserver variability in the sonographic assessment of fatty liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of iron in nonalcoholic fatty liver disease: the story continues

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/1753-0407.12056

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26998471&oldid=1588089891"